← 返回

NK 细胞作为肿瘤免疫治疗中的强效治疗工具

英文原题:NK cells as powerful therapeutic tool in cancer immunotherapy.

查看英文原题

NK cells as powerful therapeutic tool in cancer immunotherapy.

PubMed 2024/01/03(内容时间) Cell Oncol (Dordr) Q1 · IF 5.6(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

本综述全面描述了针对肿瘤的 NK 细胞治疗策略,并讨论了这些治疗策略当前存在的问题以及 NK 细胞治疗肿瘤的前景。

中文摘要

自然杀伤(NK)细胞因不受主要组织相容性复合体限制的广谱识别能力,且可快速应答并清除靶细胞,近年来受到广泛关注,具有肿瘤免疫治疗潜力。可用于人工制备治疗性NK细胞的材料包括外周血单个核细胞(PBMC)、脐带血(UCB)、诱导多能干细胞(iPSC)及NK细胞系。通过体内或体外治疗方式利用NK细胞治疗肿瘤,已取得积极疗效。

本综述全面介绍基于NK细胞的肿瘤治疗方法,讨论这些治疗策略目前存在的问题及未来前景。

展开英文摘要原文

Natural killer (NK) cells have gained considerable attention and hold great potential for their application in tumor immunotherapy. This is mainly due to their MHC-unrestricted and pan-specific recognition capabilities, as well as their ability to rapidly respond to and eliminate target cells. To artificially generate therapeutic NK cells, various materials can be utilized, such as peripheral blood mononuclear cells (PBMCs), umbilical cord blood (UCB), induced pluripotent stem cells (iPSCs), and NK cell lines. Exploiting the therapeutic potential of NK cells to treat tumors through in vivo and in vitro therapeutic modalities has yielded positive therapeutic results.

This review provides a comprehensive description of NK cell therapeutic approaches for tumors and discusses the current problems associated with these therapeutic approaches and the prospects of NK cell therapy for tumors.

论文信息

作者
Huang M、Liu Y、Yan Q、Peng M、Ge J、Mo Y、Wang Y、Wang F
第一作者单位
NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Affiliated Cancer Hospital of Xiangya School of Medicine, Hunan Cancer Hospital, Central South University, Changsha, China.China
通讯作者单位
NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Affiliated Cancer Hospital of Xiangya School of Medicine, Hunan Cancer Hospital, Central South University, Changsha, China. xiongwei@csu.edu.cn.China
文献类型
综述
期刊
Cellular oncology (Dordrecht, Netherlands)2024 Jun
原文标识
PubMed 38170381 · DOI 10.1007/s13402-023-00909-3